Sun Pharma arm to launch Bempedoic Acid to treat bad cholesterol in India Ruchika Sharma19 May 2022 11:00 AM ISTBrillo is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents.
Drug alert: CDSCO flags 27 medicine batches as not of standard quality Ruchika Sharma14 May 2022 2:48 PM ISTNew Delhi: In its latest drug safety alert, the Central Drugs Standard Control Organization (CDSCO) has flagged 27 medicine batches as not of Standard...
Sun Pharma bags USFDA nod for generic Mesalamine ER capsules to treat bowel disease Ruchika Sharma13 May 2022 11:49 AM ISTMumbai: Pharma major, Sun Pharmaceutical Industries Limited, has recently announced that the company has received final approval from US Food and Drug...
Sun Pharma gets 10 USFDA observations for Halol facility Ruchika Sharma10 May 2022 1:04 PM ISTMumbai: Pharma major, Sun Pharma, today announced that US Food and Drug Administration (USFDA) has recently concluded the Good Manufacturing...
Sun Pharma, Aurobindo, Jubilant recall products in US Ruchika Sharma25 April 2022 11:48 AM ISTThe USFDA has classified the recalls as Class III, which is initiated in a " situation in which use of, or exposure to, a violative product is not...
Ahead of Sitagliptin going off-Patent, NPPA moves to fix retail price of its FDC Meghna A Singhania15 April 2022 5:22 PM ISTNew Delhi: With the popular antidiabetic drug Sitagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
Fact Check: No, Sun Pharma is not giving RS 6000 worth gifts on its 40th Anniversary Dr. Divya Colin9 April 2022 3:00 PM ISTSun Pharma recently warned about recent a fake website misguiding public
Sun Pharma to market its own version of Vortioxetine, signs agreement with Lundbeck MD Bureau31 March 2022 12:02 PM ISTVortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder in adults.
Sun Pharma arm presents phase 3 data for acne vulgaris cream WINLEVI at AAD meeting Ruchika Sharma26 March 2022 11:48 AM ISTWINLEVI is the first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years.
Sun Pharma settles litigation against Diovan, Nexium, Valcyte Ruchika Sharma25 March 2022 12:25 PM ISTThe company has agreed to enter a comprehensive settlement with plaintiff groups for a total settlement amount of USD 485 million.
Sun Pharma to acquire Daiichi's 11.28 percent stake in Zenotech MD Bureau22 March 2022 4:34 PM ISTAfter the acquisition, Sun Pharma's stake in Zenotech will increase from 57.56 percent to 68.84 percent.
Present more data on unmet medical need for Tildrakizumab: CDSCO Panel tells Sun pharma Dr. Divya Colin20 March 2022 12:30 PM ISTNew Delhi: In response to the drug-major Sun Pharma's phase 3 protocol for immunomodulator Tildrakizumab, the Subject Expert Committee (SEC)...
